ArticleHospital pharmacy2022

Cost-Effectiveness Analysis of New Beta-Lactam Beta-Lactamase Inhibitor Antibiotics Versus Colistin for the Treatment of Carbapenem-Resistant Infections.

Monica L Bianchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.